Simulations Plus, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
SLP Nasdaq 2830 www.simulations-plus.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Simulations Plus, Inc.

[Latest] Global In Silico Clinical Trials Market Size/Share Worth USD 8.94 Billion by 2035 at a 15.2% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - Jun 26th, 2026 12:30 am
Simulations Plus Advances Agentic Drug Development with NVIDIA BioNeMo Agent Toolkit - Jun 23rd, 2026 7:15 am
Certara (CERT) Stock Sees Fair Value Edges Lower As Analysts Trim Targets - Jun 19th, 2026 7:09 pm
Lyft upgraded, Leidos downgraded: Wall Street's top analyst calls - Jun 17th, 2026 7:47 am
Altaris to acquire Simulations Plus in $375m all-cash deal - Jun 17th, 2026 3:56 am
Sector Update: Tech Stocks Fall Tuesday Afternoon - Jun 16th, 2026 11:31 am
Why Shares in Simulation Plus Soared Today - Jun 16th, 2026 11:24 am
Simulations Plus to Be Acquired by Altaris For Approximately $375 Million - Jun 16th, 2026 7:00 am
Dividend Investors: Don't Be Too Quick To Buy SLP Resources Berhad (KLSE:SLP) For Its Upcoming Dividend - Jun 11th, 2026 5:50 pm
Is It Too Late To Consider Buying Simulations Plus, Inc. (NASDAQ:SLP)? - May 29th, 2026 4:11 am
Simulations Plus to Participate in the 23rd Annual Craig-Hallum Institutional Investor Conference - May 21st, 2026 2:05 pm
This Analyst Just Made A Huge Upgrade To Their SLP Resources Berhad (KLSE:SLP) Earnings Forecasts - May 12th, 2026 4:35 pm
Simulations Plus and NVIDIA Collaborate to Scale GPU-Accelerated, AI-Assisted Modeling Workflows - May 6th, 2026 5:55 am
Do Options Traders Know Something About Simulations Plus Stock We Don't? - May 4th, 2026 10:53 am
Biosimulation Market Research and Global Forecast Report 2026-2036: Expansion Driven by Precision Medicine, AI-Powered In-Silico Drug Development and Rising Demand for Cost-Efficient Clinical Trials - Apr 22nd, 2026 8:33 am
Simulations Plus Announces Collaboration with Lonza and U.S. FDA to Advance Predictive Frameworks for Complex Oral Drug Products - Apr 21st, 2026 5:55 am
Badger Meter's Q1 Earnings & Revenues Miss Estimates, Stock Dips - Apr 20th, 2026 8:04 am
Simulations Plus Expands Global Access to Model-Informed Drug Development Training Through Its 2026 Spring School - Apr 20th, 2026 5:55 am
Here’s Simulations Plus Inc (SLP)’s Vision for AI in Drug Development - Apr 19th, 2026 2:51 pm
How The Sylvania Platinum (AIM:SLP) Story Is Shifting As Valuation Tweaks Meet New Guidance - Apr 18th, 2026 2:03 am